The platform is based on over a decade of experimental research and a human biology network map that describes how proteins interact to cause disease phenotypes and helps interpret patient molecular data.
People in the US suffer in silence from autoimmune disease. These patients are put on a treatment journey of trial and error, trying one expensive drug after another until they inevitably fail.
The Lancet article discusses technological approaches to understanding and monitoring COVID-19 and searching for treatments, noting that the pandemic has focused global efforts on using technology.
The combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA), using Scipher’s AI Network Medicine platform.
Scipher Medicine is a precision immunology company on a mission to match each patient with their most effective therapy and bring forward the day when every autoimmune disease patient reaches remission, and no one suffers in silence.
Living at the crossroads of precision medicine and AI, Scipher Medicine is a precision immunology company on a mission to match each patient with their most effective therapy.
